Aaron J. Kowalski, Ph.D., CEO of Breakthrough T1D, spoke with Managed Healthcare Executive, talks about the possible impacts ...

The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.

The NIH projected the cut will save it $4 billion during the current federal fiscal year, which ends September 30. That’s nearly half of the $9 billion that the NIH said it set aside for overhead ...

While some argue that trimming these costs is a reasonable measure since some for nonprofit funders like the Carnegie ...